Studies have shown that targeting MAFs and MAF-related pathways has an ideal effect on the treatment of metastatic tumors in terms of alleviating tumor metastases and reversing resistance to various therapeutic strategies. The gene discussed is MAF; the disease is metastatic neoplasm.